Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
The highly-anticipated fifth edition is here! Get the must-have resource for achieving compliance with medical device regulations.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 02 May 2013 | By Louise Zornoza,
Brazil's National Health Surveillance Agency (Anvisa) has opened a Public Consultation on proposed Good Regulatory Practices (GRPs), which establishes the standards and procedures that are to be followed by the agency in the development of regulatory measures.
The proposals include a mechanism that would enable Anvisa to assess the best regulatory measure to achieve an intended regulatory goal, which would complement the Regulatory Impact Analysis process. That process is used to assesses the likely benefits, costs and impact of proposed regulations.
Anvisa said it sees the new consultation as part of a continuing process by which the agency will provide greater transparency on its regulatory conduct and responsibilities.
Anvisa: Anvisa lança Consulta Pública sobre Boas Práticas Regulatórias
Read all Breaking News from RegLink
Tags: brazil